Education
| 1964 |
School of Hygiene & Public Health, Johns Hopkins University |
SC.D. |
|
| 1962 |
School of Hygiene & Public Health, Johns Hopkins University |
SC.M. |
|
| 1958 |
Towson State College |
B.S. |
|
Professional Positions
Academic Positions
1967-1969 |
Assistant Professor of Biostatistics & Epidemiology
Johns Hopkins University School of Hygiene & Public Health |
1974-1975 |
Visiting Scientist
Oxford University, UK |
1994 (Sep-Dec) |
Visiting Scientist
Columbia University |
1995 (Jan to Aug) |
Visiting Scientist
Stanford University |
2004-2005 |
Visiting Scientist
Johns Hopkins University |
Non-Academic Positions
|
1969-2006 |
Food & Drug Administration, Rockville, Maryland |
|
1998-2006 |
Deputy Office Director, Office of Biostatistics, Office of
Pharmacoepidemiology and Statistical Science (Center
For Drug Evaluation and Research, FDA)
|
1984-1998 |
Deputy Office Director, Office of Epidemiology and
Biostatistics (Center for Drug Evaluation and Research, FDA)
|
|
1972-1984 |
Director, Division of Biometrics (Center for Drugs and
Biologics, FDA)
|
1970-1972 |
Director, Division of Biometry and Epidemiology
(Office of Scientific Coordination, Bureau of Drugs, FDA) |
1969-1970 |
Director, Division of Statistics
(Office of Scientific Coordination, Bureau of Drugs, FDA)
|
1965-1967 |
Statistics Group Research Analysis Corporation
(McLean, VA) Principal Investigator |
1964-1965 |
Booz-Allen Applied Research (Bethesda, MD)
Statistical Consultant |
1953-1961 |
Military: U.S. Naval Reserves (Inactive) |
Selected Publications
Books and monographs
Anello C., Arrowsmith J. Chapter 7: Pharmacoepidemiology: The View from a Regulatory Agency" New York pp. 69-84. Strom, B. (Ed.) (1989)
Baum C., Anello C. Chapter 9: Pharmacoepidemiology: "The Spontaneous Reporting System in the United States" New York, pp. 107-118. Strom, B. (ED). (1989)
Anello C. "The Use, Design, and Limitation of Selected Phase IV Studies in the United States" (1983) Post Marketing Clinical Trials, the phase IV studies, proceeding of the International conference held in Paris, France, 26-27 September
Anello, C. "FDA Statistical Programs: An Overview." Encyclopedia of Statistical Sciences, John Wiley (1982).
Anello, C., Ruskin, A."Monitoring for Drug Safety." The United States of America (Chapter 12). Inman, WH (ed), MTP Press Limited (1980). Pp. 153-163.
Anello, C. "Considerations of Significance- Clinical and Statistical." Principles and Techniques of Human Research and Therapeutics, Vol IV. "Importance of Experimental Design and Biostatistics." Hagans and Peltier (eds), Futura Publication Company pp. 5-18 (1974)
Articles
Anello C., R. O'Neill and S. Dubey. "Multicentre trials: A U.S. regulatory Perspective," Statistical Methods in Research ,14: pp. 1-15 (2005).
Anello C., Hyman F. "Met-analysis: Its role in the drug approval process and the implications for Evidence Based Dentistry," Journal of Evidence Based Dental Practice, Volume 4, No. 1, pp. 52-58, (2004).
Anello C. "Emerging and Recurrent Issues in Drug Development." DeMontfort University, Leicester, UK, Statistics in Medicine, 18, 2301-2309 (1999).
R. D'Agostino, M. Weintraub, H. Russell, M. Stepanias, L. Cantilena, J. Graumlich, S. Maldonado, Honig, P., Anello C. "The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: A meta-analysis," Clinical Pharmacology and Therapeutics, Vol. 64 No. 6 pp. 579-596, Dec. 1998.
Anello C., O'Neill R.T. "Does Research Synthesis Have a Place in Drug Development Policy?" Synopsis of Issues: Assessment of Safety and Postmarketing Surveillance. Clinical Research & Regulatory Affairs 13(I) 13-21 (1996).
|
